Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?
A year after Vertex’s big launch, pain drug research faces a pivotal moment
A year after Vertex’s big launch, pain drug research faces a pivotal moment is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: BioPharma Dive